Unigene Claims $64.2M Liabilities In Ch. 7 Petition
The filing follows a troubling year for the drugmaker, including a loss of revenue from its osteoporosis nasal spray, Fortical, with warnings earlier this year that if the company failed to restructure debt owed to Victory Park Capital and its founders, it wouldn't be able to continue operations, according to regulatory filings.
The company lists $394,022 in...
To view the full article, register now.